Interventional Cardiology Devices Market To Reach $19.75 Billion By 2033

Interventional Cardiology Devices Market Growth & Trends

The global interventional cardiology devices market size is expected to reach USD 19.75 Billion by 2033, registering a CAGR of 7.25% from 2025 to 2033, according to a new report by Grand View Research, Inc. Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe. 

Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.

 Request a free sample copy or view report summary: Interventional Cardiology Devices Market Report

Interventional Cardiology Devices Market Report Highlights

• The coronary stents segment dominated the market with the largest revenue share of 49.78% in 2024. DES makes up the majority of sales in the coronary stent category.

• Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period

• North America dominated the interventional cardiology devices market with a revenue share of 45.06% in 2024, owing to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and early adoption of innovative technologies.

• The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence

Interventional Cardiology Devices Market Segmentation

Grand View Research, Inc. has segmented the global Interventional cardiology devices market report based on product and region:

Interventional Cardiology Devices Product Outlook (Revenue, USD Million, 2021 - 2033)

• Coronary Stents

  • DES

  • BMS

  • BRS

• PTCA Balloon Catheters

• Normal

• Specialty

• Drug-Coated

• Intravascular Imaging Catheters and Pressure Guidewires 

• Accessory Devices

  • PTCA Guidewires

  • PTCA Guiding Catheters

  • Introducer Sheaths

Interventional Cardiology Devices Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • Italy

  • Spain

  • France

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • China

  • India

  • Japan

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Interventional Cardiology Devices Market

• Abbott

• Medtronic plc

• Boston Scientific Corporation

• Cardinal Health, Inc.

• Koninklijke Philips N.V.

• Terumo Corporation

• Alvimedica Medical Technologies Inc.

• Teleflex Incorporated

• B. Braun Melsungen AG

• Biosensors International Group, Ltd.

• Meril Life Sciences Pvt. Ltd.

• BIOTRONIK SE & Co. KG

• ACIST Medical Systems, Inc.

• Asahi Intecc Co., Ltd.

• Cook Medical LLC

• Medinol Ltd.

• Merit Medical Systems, Inc.

• NuMED, Inc.

• OpSens Inc.

• Zeon Medical Inc.